FDA Warning Letter — Exxon

Case 681161 — FEI 3015272031

The FDA took a Warning Letter action against Exxon on Apr 2, 2024 (Roselle, NJ). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon
Date
Apr 2, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Roselle, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.